{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:31:43Z","timestamp":1770064303547,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/iae.0b013e318295f6de","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T12:54:38Z","timestamp":1371819278000},"page":"157-164","source":"Crossref","is-referenced-by-count":52,"title":["MICROANEURYSM FORMATION RATE AS A PREDICTIVE MARKER FOR PROGRESSION TO CLINICALLY SIGNIFICANT MACULAR EDEMA IN NONPROLIFERATIVE DIABETIC RETINOPATHY"],"prefix":"10.1097","volume":"34","author":[{"given":"Christos","family":"Haritoglou","sequence":"first","affiliation":[]},{"given":"Marcus","family":"Kernt","sequence":"additional","affiliation":[]},{"given":"Aljoscha","family":"Neubauer","sequence":"additional","affiliation":[]},{"given":"Joachim","family":"Gerss","sequence":"additional","affiliation":[]},{"given":"Carlos Manta","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Anselm","family":"Kampik","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Ulbig","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-22-20210130","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.2337\/diacare.21.3.C11","article-title":"Diabetes in America: epidemiology and scope of the problem.","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"R2-22-20210130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-22-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/oxfordjournals.aje.a113725","article-title":"Prevalence of diabetes mellitus in southern Wisconsin.","volume":"119","author":"Klein","year":"1984","journal-title":"Am J Epidemiol"},{"key":"R5-22-20210130","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1.","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R6-22-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":". Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.","volume":"26","author":"Haritoglou","year":"2006","journal-title":"Retina"},{"key":"R7-22-20210130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"; RESTORE study group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"R8-22-20210130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(09)60218-X","article-title":"; The CALDIRET Study Group. The calcium dobesilate (Dexium) in diabetic retinopathy (CALDIRET)study: final results.","volume":"373","author":"Haritoglou","year":"2009","journal-title":"Lancet"},{"key":"R9-22-20210130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic colour fundus photographsan extension of the modified Arlie House classification EDTRS report number 10.","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"R10-22-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000213638","article-title":". Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy.","volume":"223","author":"Bernardes","year":"2009","journal-title":"Ophthalmologica"},{"key":"R11-22-20210130","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1167\/iovs.02-0951","article-title":". Automated measurement of microaneurysm turnover.","volume":"44","author":"Goatman","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-22-20210130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1109\/TMI.2006.879953","article-title":"Automated microaneurysm detection using local contrast normalization and local vessel detection.","volume":"25","author":"Fleming","year":"2006","journal-title":"IEEE Trans Med Imaging"},{"key":"R14-22-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000213639","article-title":". Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.","volume":"223","author":"Nunes","year":"2009","journal-title":"Ophthalmologica"},{"key":"R17-22-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: predictive values.","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"R18-22-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/biomet\/78.1.153","article-title":"Generalized estimating equations for correlated binary data: using the odds ratio as a measure of association.","volume":"78","author":"Lipsitz","year":"1991","journal-title":"Biometrika"},{"key":"R19-22-20210130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEIFDA Ophthalmic Clinical Trial Design and Endpoints Symposium.","volume":"49","author":"Csaky","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-22-20210130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1464-5491.2010.03210.x","article-title":". Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.","volume":"28","author":"Sjolie","year":"2011","journal-title":"Diabet Med"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e318295f6de","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T19:17:47Z","timestamp":1715541467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201401000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318295f6de","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}